Compare HOV & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOV | THW |
|---|---|---|
| Founded | 1959 | N/A |
| Country | United States | United States |
| Employees | 1891 | N/A |
| Industry | Homebuilding | Finance Companies |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 645.8M | 516.7M |
| IPO Year | N/A | 2015 |
| Metric | HOV | THW |
|---|---|---|
| Price | $122.02 | $12.36 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $97.00 | N/A |
| AVG Volume (30 Days) | 95.7K | ★ 96.4K |
| Earning Date | 05-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.96 | N/A |
| P/E Ratio | $17.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $90.79 | $10.13 |
| 52 Week High | $162.06 | $13.19 |
| Indicator | HOV | THW |
|---|---|---|
| Relative Strength Index (RSI) | 61.65 | 43.43 |
| Support Level | $117.28 | $11.87 |
| Resistance Level | $127.22 | $12.95 |
| Average True Range (ATR) | 5.58 | 0.27 |
| MACD | 1.36 | -0.06 |
| Stochastic Oscillator | 79.68 | 30.50 |
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.